… This past October, Austrian biotech AFFiRiS announced $1.5 million in … disease (PD), called PD01. Then, in November, the company announced 30 million Euros in additional funding … Chief Medical Officer Achim Schneeberger about  PD01, and how it could work to break up the clumps of the protein …

… Born and raised in Colombia, Diana Rodriguez, age 39, moved to Canada as a teenager. Now a business coach and dedicated … painting, designing, theatre or special effects makeup. However, since her diagnosis of Parkinson’s disease, Diana's passions have become more challenging. Diana’s first sign of Parkinson’s was …

… is impaired. Some of the circRNAs have been linked to genes and proteins that play a role in Parkinson's … used incorrectly in the brain regions affected by PD. By comparing brain tissue of people with Parkinson's with that … for studying whether circRNAs are involved in PD and if so, how. If circRNAs are indeed involved, they could constitute …

… clear link between the LRRR2 gene and Parkinson’s disease. To what extent and by what mechanisms LRRK2 contributes to … analyses in peripheral blood mononuclear cells (PBMCs). By comparing PBMCs with different amounts of LRRK2 protein … Parkinson’s Disease:                      This study will show to what extent LRRK2 plays a role in sporadic PD and …

… Research projects from five biopharmaceutical companies in the United States, Canada and Israel comprise the 2013 first half of The Michael J. Fox … participants’ research projects are presented directly to industry groups who may wish to invest in further …

… that guide protein movement around cells, are linked to Parkinson's disease (PD). We have identified a group of … (called synapses) and thereby prevent defects in neuronal communication that occur in PD from alpha-synuclein … buildup. Any Rabs with these properties could be targeted by screening for chemical compounds that stimulate …